CEO

Michael Maglin is the CEO of CraniUS Therapeutics, where he leads the development and commercialization of NeuroPASS™, a groundbreaking intracranial drug delivery system designed to bypass the blood-brain barrier for chronic therapeutic delivery. With over 25 years of leadership experience, including his tenure at Under Armour as Vice President of North America Digital Revenue, Michael has a proven track record in digital transformation and growth. At Under Armour, he spearheaded initiatives resulting in over $1 billion in digital revenue, integrated health and fitness app ecosystems, and launched wearable technologies. Before that, he held leadership roles at Colgate-Palmolive and ConAgra Foods, managing multimillion-dollar brand portfolios and achieving market leadership. Driven by a passion for impactful innovation, Michael now dedicates his expertise to advancing treatments for brain diseases, offering hope to patients and families worldwide.